Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Spector

Showing results (861-870 of 939) with videos related to

Pageof 94
Sort By:
Science Advances|April 18, 2020
The surface stress of biomedical silicones is a stimulant of cellular responseZhu Cheng, Carolyn R Shurer, Samuel Schmidt, et al.
AIDS (London, England)|December 24, 2013
Pediatric treatment 2.0: ensuring a holistic response to caring for HIV-exposed and infected childrenShaffiq M Essajee, Stephen M Arpadi, Eric J Dziuban, et al.
Annals of Neurology|January 13, 2000
Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic ParalysisR Tawil, M P McDermott, R Brown, et al.
Japanese Journal of Clinical Oncology|August 21, 2007
Neoadjuvant, surgery and adjuvant chemotherapy without radiation for esophageal cancerBach Ardalan, Seth A Spector, Alan S Livingstone, et al.
Acta Biomaterialia|April 21, 2019
Microstructured hydrogel scaffolds containing differential density interfaces promote rapid cellular invasion and vascularizationKarel-Bart Celie, Yoshiko Toyoda, Xue Dong, et al.
The Journal of Biological Chemistry|November 13, 2003
20-hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cellsTerry L Kaduce, Xiang Fang, Shawn D Harmon, et al.
ACS Biomaterials Science & Engineering|February 24, 2025
Designing Positionally Stable Smooth Breast ImplantsTim Y Li, Sophia Salingaros, Hector F Salazar, et al.
Journal of the Pediatric Infectious Diseases Society|November 20, 2015
Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of AgeSharon Nachman, Carmelita Alvero, Edward P Acosta, et al.
The Journal of Pediatrics|May 25, 2012
Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virusJorge Lujan-Zilbermann, Meredith G Warshaw, Paige L Williams, et al.
Human Vaccines & Immunotherapeutics|February 2, 2013
High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088)Adriana Weinberg, Petronella Muresan, Terence Fenton, et al.
Pageof 94

Showing results (861-870 of 939) with videos related to

Sort By:
Pageof 94
Science Advances|April 18, 2020
The surface stress of biomedical silicones is a stimulant of cellular responseZhu Cheng, Carolyn R Shurer, Samuel Schmidt, et al.
AIDS (London, England)|December 24, 2013
Pediatric treatment 2.0: ensuring a holistic response to caring for HIV-exposed and infected childrenShaffiq M Essajee, Stephen M Arpadi, Eric J Dziuban, et al.
Annals of Neurology|January 13, 2000
Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic ParalysisR Tawil, M P McDermott, R Brown, et al.
Japanese Journal of Clinical Oncology|August 21, 2007
Neoadjuvant, surgery and adjuvant chemotherapy without radiation for esophageal cancerBach Ardalan, Seth A Spector, Alan S Livingstone, et al.
Acta Biomaterialia|April 21, 2019
Microstructured hydrogel scaffolds containing differential density interfaces promote rapid cellular invasion and vascularizationKarel-Bart Celie, Yoshiko Toyoda, Xue Dong, et al.
The Journal of Biological Chemistry|November 13, 2003
20-hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cellsTerry L Kaduce, Xiang Fang, Shawn D Harmon, et al.
ACS Biomaterials Science & Engineering|February 24, 2025
Designing Positionally Stable Smooth Breast ImplantsTim Y Li, Sophia Salingaros, Hector F Salazar, et al.
Journal of the Pediatric Infectious Diseases Society|November 20, 2015
Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of AgeSharon Nachman, Carmelita Alvero, Edward P Acosta, et al.
The Journal of Pediatrics|May 25, 2012
Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virusJorge Lujan-Zilbermann, Meredith G Warshaw, Paige L Williams, et al.
Human Vaccines & Immunotherapeutics|February 2, 2013
High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088)Adriana Weinberg, Petronella Muresan, Terence Fenton, et al.
Pageof 94